Abiopharma

News list

📋 Schoenberg Mark (Officer) plans to sell 61K shares of UroGen Pharma Ltd. (at $47.67 each, total $2.9M) Filed: Aug 20, 2026 | ID: 000100

Full text

News bot Aug. 20, 2026, 5:25 p.m.
📋 Form 144 Filing: Schoenberg Mark

Company: UroGen Pharma Ltd.

Filing Date: 2026-08-20

Relationship: Officer
Planned Sale Details:
- Security: COMMON
- Shares to be Sold: 60,677
- Price per Share: $47.67
- Total Value: $2,892,242.00
- Planned Sale Date: 2026-08-20
- Broker: RBC CAPITAL MARKETS LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38079
- Issuer Contact Phone: 972 9 770 7601
- Issuer Address: 9 HA'TA'ASIYA ST, RA'ANANA, L3, 4365007
- Broker Address: 250 NICOLLET MALL, SUITE 1700, MINNEAPOLIS, MN, 55401
- Shares Outstanding: 48880564.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Signature: POA / JEFFREY EISCHENS